COSCIENS Biopharma Inc. is a life science company focused on the development and commercialization of natural, plant-based active ingredients derived from oats and other renewable plant resources using proprietary manufacturing and extraction technologies. The company's primary business activities involve creating natural products for the personal care, cosmetic, human and animal health industries through its core technologies and distribution network. COSCIENS generates revenue primarily from the sale of active ingredients such as beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, and oat peptides to customers in the personal care, cosmetic, medical, and animal health sectors via distribution partners and direct sales. A small portion of current revenues also comes from veterinary therapeutic products including an oat shampoo, an ear cleanser, and a dermal complex/conditioner marketed to veterinarians in Japan and other Asian countries.
The company generates revenue through the commercialization of its natural active ingredient portfolio, which is developed and produced using proprietary extraction technologies. Sales are driven by a commercial line of oat-derived ingredients including beta glucan, avenanthramides, oat powder, oat oil, and oat peptides, which are marketed to the personal care, cosmetic, medical, and animal health industries. COSCIENS relies on a distribution network strategy, selling principally through partners rather than directly to end-users, which keeps sales and marketing expenses low. Revenue is also supported by limited life licence agreements for exclusive rights to new technologies, which the company works to develop and scale up for commercialization.
The company operates through the following segments:
- Active Ingredients: This segment focuses on the development and commercialization of natural, plant-based active ingredients derived from oats and other renewable resources. The segment produces and markets beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, and oat peptides for use in personal care, cosmetic, human health, and animal health applications. These ingredients are sold through distribution partners and direct sales channels to manufacturers in the personal care, cosmetic, medical, and animal health industries.
- Veterinary Therapeutics: This segment manufactures and markets veterinary therapeutic products including an oat shampoo, an ear cleanser, and a dermal complex/conditioner. These products are specifically formulated and marketed to veterinarians in Japan and other countries in Asia. The segment leverages the company's expertise in oat-based formulations to address animal health needs in companion animals.
- Technology Development: This segment encompasses the company's proprietary extraction and processing technologies, including the Ethanol Fractionation Process (EFP) and Pressurized Gas eXpanded (PGX) Technology. EFP is used to produce liquid active ingredient formulations, while PGX Technology is a patented process that purifies, micronizes, dries, and combines biopolymer solutions using carbon dioxide and food grade ethanol. The segment focuses on scaling up PGX Technology through collaborations, including with NATEX Prozesstechnologie GesmbH in Austria, to enable production of specialty materials such as aerogels for potential use in functional foods, nutraceuticals, cosmeceuticals, and pharmaceuticals.
COSCIENS holds a niche position in the natural active ingredients market, particularly in oat-derived compounds like avenanthramides and beta glucan, where it leverages proprietary technologies to differentiate its offerings. The company competes with other suppliers of natural ingredients and specialty chemicals in the personal care and cosmetic industries, though its focus on oat-based innovation and green extraction technologies provides a competitive edge. Its PGX Technology, capable of producing aerogels and other high-value biocomposites using environmentally friendly processes, represents a unique advantage not commonly found among conventional drying and purification methods used by competitors.
The company's customer base consists primarily of manufacturers and formulators in the personal care, cosmetic, medical, and animal health industries who purchase its active ingredients for incorporation into finished products. Over 84% of the company's sales and related accounts receivable are derived from a single distribution partner, Symrise AG, a global supplier of fragrances, flavors, food nutrition, and cosmetic ingredients. Additional customers include veterinarians in Japan and other Asian countries who purchase the company's veterinary therapeutic products such as oat shampoo, ear cleanser, and dermal complex/conditioner.